Mineral Oil
NDC 50382-009

View NDC Profile UNII Mappings and RxNorm Concepts.

Product Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mineral Oil is a OTC MONOGRAPH NOT FINAL-approved product labeled by Galentic Pharma (india) Priva Te Limited. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 50382-009 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.

Primary Identification

NDC Product Code:
50382-009
Proprietary Name:
Mineral Oil
Product Type: [3]
INACTIVATED PRODUCT and EXCLUDED the from NDC Directory
Code Navigator:

Labeler & Regulatory Data

Labeler Code:
50382
FDA Application Number: [6]
part334
Marketing Category: [8]
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.

Marketing Timeline

Start Marketing Date: [9]
08-07-2013
Listing Expiration Date: [11]
12-31-2017
Exclude Flag: [12]
I

Code Structure Chart

Product Details

What is NDC 50382-009?

The NDC code 50382-009 is assigned by the FDA to the product Mineral Oil. This pharmaceutical product is labeled by Galentic Pharma (india) Priva Te Limited and is currently categorized as listed product. In terms of distribution, this product is available in a single package configuration. The associated package NDC(s) include: 50382-009-01. Beyond standard identification, this entry provides technical data including pharmacologic classes, UNII ingredient references, and RxNorm cross-referencing for healthcare systems.

What are the uses of this product?

Single daily doseAdults and children 12 years and older - 1 bottleChildren 2 to under 12 years - 1/2 bottleChildren under 2 years - Do not use. Consult a physician.How to use this enema:REMOVE GREEN PROTECTIVE SHIELD BEFORE INSERTING.Hold bottle upright, grasping bottle cap with fingers. Grasp protective shield with the other hand and pull gently to remove.See image on boxPositioningLeft-side position: Lie on left side with knee bent and arms at rest.See image on boxKnee-chest position: Kneel, then lower head and chest forward until the left side of face is resting on surface. Position arms comfortably.See image on boxAdministering EnemaWith steady pressure, gently insert enema with tip pointing toward navel.Squeeze bottle until recommended dose is expelled (it is not necessary toempty unit completely. Bottle contains more liquid than needed for effectiveuse. A small amount of liquid will remain in bottle after squeezing).Remove tip from rectum.Stop using if tip is hard to insert. Forcing the tip into the rectum cancause injury (especially if you have hemorrhoids). If enema tip causesrectal bleeding or pain, get immediatemedical care.Maintain position until urge to evacuate is strong (usually 1 to 5 minutes).If no urge is felt after 5 minutes of using, try to empty bowel. Call a doctorpromptly if no liquid comes out of the rectum after 30 minutes becausedehydration could occur.

Which are the associated UNII Codes?

The UNII codes for the active ingredients in this product are:

What is the NDC to RxNorm Crosswalk for this product?

RxNorm is a normalized naming system for generic and branded drugs that assigns unique concept identifier(s) known as RxCUIs to NDC products.The NDC to RxNorm Crosswalk for this produdct indicates multiple concept unique identifiers (RXCUIs) are associated with this product:

* Please review the full disclaimer at the bottom of this page.

Product & Regulatory Definitions
What is the Labeler Name? Name of Company corresponding to the labeler code segment of the Product NDC.
What is the FDA Application Number? This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
What is the Marketing Category? Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
What is the Start Marketing Date? This is the date that the labeler indicates was the start of its marketing of the drug product.
What is the Listing Expiration Date? This is the date when the listing record will expire if not updated or certified by the product labeler.
What is the NDC Exclude Flag? This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions, or because the listing certification is expired, or because the listing data was inactivated by FDA, or because it was discontinued by the labeler. Possible values in this field are: "D", "E", "I", "N", "U".